MRI-based identification of undifferentiated cells: looking at the two faces of Janus
Ciprian Tomuleasa,1,2 Ioan Stefan Florian,3 Cristian Berce,4 Alexandru Irimie,5,6 Ioana Berindan-Neagoe,2,7,9 Andrei Cucuianu1,8 1Department of Hematology, Ion Chiricuta Cancer Center, Cluj Napoca, Romania; 2Research Center for Functional Genomics and Translational Medicine, Iuliu Hatieganu Univers...
Guardado en:
Autores principales: | Tomuleasa C, Florian IS, Berce C, Irimie A, Berindan-Neagoe I, Cucuianu A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d3eb0d897a284d5cb42ea72f71ad18f1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Sorafenib for the treatment of solid malignancies: what about the cancer microenvironment?
por: Tomuleasa C, et al.
Publicado: (2013) -
Dose intensity and autologous stem cell transplantation as salvage therapy for pediatric primary CNS malignancies
por: Kojima S, et al.
Publicado: (2014) -
Nanopharmacology in translational hematology and oncology
por: Tomuleasa C, et al.
Publicado: (2014) -
Combining the chemotherapeutic effects of epigallocatechin 3-gallate with siRNA-mediated p53 knock-down results in synergic pro-apoptotic effects
por: Berindan-Neagoe I, et al.
Publicado: (2012) -
Small molecules against B-RAF (BRAF) Val600Glu (V600E) single mutation
por: Zaharie F, et al.
Publicado: (2015)